Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 15, 2013, Pages 6091-6096

  Tang, Jian Zhong ^a   Carmichael, Catherine L ^a,b   Shi, Wei ^a,b   Metcalf, Donald ^a,b   Ng, Ashley P ^a,b   Hyland, Craig D ^a   Jenkins, Nancy A ^b   Copeland, Neal G ^b   Howell, Viive M ^c   Zhao, Zhizhuang Joe ^d   Smyth, Gordon K ^a,e   Kile, Benjamin T ^a,b   Alexander, Warren S ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; TRANSCRIPTION FACTOR ETS;

ACUTE MEGAKARYOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL TRANSFORMATION; CONTROLLED STUDY; ERYTHRO MEGAKARYOCYTIC LEUKEMIA; ERYTHROID CELL; GENE; GENE INSERTION; GENE LOCUS; GENETIC CODE; LIPOSARCOMA; LIVER CELL; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSPOSON;

ALLELES; ANIMALS; DNA TRANSPOSABLE ELEMENTS; GENE EXPRESSION REGULATION, LEUKEMIC; GENOTYPE; JANUS KINASE 2; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, MEGAKARYOBLASTIC, ACUTE; MICE; MICE, TRANSGENIC; MUTAGENESIS; NEOPLASM TRANSPLANTATION; ONCOGENE PROTEINS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS C-ETS; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION;

MUS;

EID: 84876041430     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1304234110     Document Type: Article

References (38)

1. Kool J, Berns A (2009) High-throughput insertional mutagenesis screens in mice to identify oncogenic networks. Nat Rev Cancer 9(6):389-399.
2. Copeland NG, Jenkins NA (2010) Harnessing transposons for cancer gene discovery. Nat Rev Cancer 10(10):696-706.
3. Dupuy AJ, et al. (2009) A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res 69(20):8150-8156.
4. Croker BA, et al. (2004) SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20(2):153-165.
5. Xing S, et al. (2008) Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice. Blood 111(10):5109-5117.
6. Scott LM (2011) The JAK2 exon 12 mutations: A comprehensive review. Am J Hematol 86(8):668-676.
7. Martens JH (2011) Acute myeloid leukemia: A central role for the ETS factor ERG. Int J Biochem Cell Biol 43(10):1413-1416.
8. Clark JP, Cooper CS (2009) ETS gene fusions in prostate cancer. Nat Rev Urol 6(8):429-439.
9. Santos FP, Bueso-Ramos CE, Ravandi F (2010) Acute erythroleukemia: Diagnosis and management. Expert Rev Hematol 3(6):705-718.
10. Zuo Z, Polski JM, Kasyan A, Medeiros LJ (2010) Acute erythroid leukemia. Arch Pathol Lab Med 134(9):1261-1270.
11. Ng AP, et al. (2011) Erg is required for self-renewal of hematopoietic stem cells during stress hematopoiesis in mice. Blood 118(9):2454-2461.
12. Loughran SJ, et al. (2008) The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat Immunol 9(7):810-819.
13. Taoudi S, et al. (2011) ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification. Genes Dev 25(3):251-262.
14. Ng AP, et al. (2010) Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome. Blood 115(19):3966-3969.
15. Rainis L, et al. (2005) The proto-oncogene ERG in megakaryoblastic leukemias. Cancer Res 65(17):7596-7602.
16. Bories JC, et al. (1995) Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 377(6550):635-638.
17. Hahne JC, et al. (2008) The transcription factor ETS-1: Its role in tumour development and strategies for its inhibition. Mini Rev Med Chem 8(11):1095-1105.
18. Goyns MH, Hann IM, Stewart J, Gegonne A, Birnie GD (1987) The c-ets-1 protooncogene is rearranged in some cases of acute lymphoblastic leukaemia. Br J Cancer 56(5):611-613.
19. Rovigatti U, Watson DK, Yunis JJ (1986) Amplification and rearrangement of Huets-1 in leukemia and lymphoma with involvement of 11q23. Science 232(4748):398-400.
20. Dadi S, et al. (2012) TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression. Cancer Cell 21(4):563-576.
21. Metz T, Graf T (1991) v-myb and v-ets transform chicken erythroid cells and cooperate both in trans and in cis to induce distinct differentiation phenotypes. Genes Dev 5(3):369-380.
22. Carmichael CL, et al. (2012) Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia. Proc Natl Acad Sci USA 109(38):15437-15442.
23. Pereira DS, et al. (1998) Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells. Proc Natl Acad Sci USA 95(14):8239-8244.
24. Lulli V, et al. (2006) Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation. Cell Death Differ 13(7):1064-1074.
25. Marziali G, et al. (2002) Role of Ets-1 in erythroid differentiation. Blood Cells Mol Dis 29(3):553-561.
26. Moreau-Gachelin F (2008) Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation. Retrovirology 5:99.
27. De Braekeleer E, et al. (2011) ABL1 fusion genes in hematological malignancies: A review. Eur J Haematol 86(5):361-371.
28. Grossmann V, et al. (2011) Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood 118(23):6153-6163.
29. Oberley MJ, Wang DS, Yang DT (2012) Vav1 in hematologic neoplasms, a mini review. Am J Blood Res 2(1):1-8.
30. Shih AH, Abdel-Wahab O, Patel JP, Levine RL (2012) The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer 12(9):599-612.
31. Shima Y, Kitabayashi I (2011) Deregulated transcription factors in leukemia. Int J Hematol 94(2):134-141.
32. Dupuy AJ, Akagi K, Largaespada DA, Copeland NG, Jenkins NA (2005) Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436(7048):221-226.
33. Glaser SP, et al. (2012) Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia. Genes Dev 26(2):120-125.
34. Alexander WS, Roberts AW, Nicola NA, Li R, Metcalf D (1996) Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood 87(6):2162-2170.
35. Keng VW, et al. (2009) A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat Biotechnol 27(3):264-274.
36. Largaespada DA, Collier LS (2008) Transposon-mediated mutagenesis in somatic cells: Identification of transposon-genomic DNA junctions. Methods Mol Biol 435:95-108.
37. Starr TK, et al. (2009) A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 323(5922):1747-1750.
38. March HN, et al. (2011) Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis. Nat Genet 43(12):1202-1209.